Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q1 2023 Earnings

23FebConfirmed

Q2 2022

Q3 2022

Q4 2022

Q1 2023

-14.36

-12.39

-10.42

-8.45

Details

Expected EPS

-10.01598

Actual EPS

-8.629152

Surprise EPS

1.39

Surprise Percent

+13.85%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -8.629152 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.